Biogen

Biogen Inc.

Headquarters in Cambridge, Massachusetts
Formerly	Biogen Idec Inc. (2003–2015)
Company type	Public
Traded as	Nasdaq: BIIB Nasdaq-100 component S&P 500 component
Industry	Biotechnology
Founded	1978; 46 years ago (1978)
Founders	Kenneth Murray Phillip Allen Sharp Walter Gilbert Heinz Schaller Charles Weissmann
Headquarters	Cambridge, Massachusetts, U.S.
Key people	Caroline Dorsa (chairman) Chris Viehbacher (CEO)
Products	Avonex Fampyra Plegridy Tecfidera Tysabri Spinraza
Revenue	US$9.836 billion (2023)
Operating income	US$1.297 billion (2023)
Net income	US$1.162 billion (2023)
Total assets	US$26.84 billion (2023)
Total equity	US$14.80 billion (2023)
Number of employees	7,570 (2023)
Website	biogen.com
Footnotes / references [1]

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland.^[2]